Found: 101
Select item for more details and to access through your institution.
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis.
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 601, doi. 10.1007/s40264-024-01419-3
- By:
- Publication type:
- Article
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 435, doi. 10.1007/s11523-024-01058-9
- By:
- Publication type:
- Article
Using artificial intelligence to create diverse and inclusive medical case vignettes for education.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 3, p. 640, doi. 10.1111/bcp.15977
- By:
- Publication type:
- Article
The European List of Key Medicines for Medical Education: A Modified Delphi Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 515, doi. 10.1002/cpt.3132
- By:
- Publication type:
- Article
Authors' Reply to Cappello et al. Comment on: "Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System".
- Published in:
- Drug Safety, 2023, v. 46, n. 9, p. 919, doi. 10.1007/s40264-023-01331-2
- By:
- Publication type:
- Article
Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2365, doi. 10.1111/bcp.15780
- By:
- Publication type:
- Article
Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 4, p. 571, doi. 10.1007/s00228-023-03465-9
- By:
- Publication type:
- Article
A Clinical Pharmacology and Therapeutics Teacher's Guide to Race‐Based Medicine, Inclusivity, and Diversity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 3, p. 600, doi. 10.1002/cpt.2786
- By:
- Publication type:
- Article
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 283, doi. 10.1007/s40264-022-01269-x
- By:
- Publication type:
- Article
Exploring the underlying mechanisms of drug‐induced impulse control disorders: a pharmacovigilance‐pharmacodynamic study.
- Published in:
- Psychiatry & Clinical Neurosciences, 2023, v. 77, n. 3, p. 160, doi. 10.1111/pcn.13511
- By:
- Publication type:
- Article
Teaching resources for the European Open Platform for Prescribing Education (EurOP<sup>2</sup>E)—a nominal group technique study.
- Published in:
- NPJ Science of Learning, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41539-022-00141-y
- By:
- Publication type:
- Article
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.
- Published in:
- International Journal of Neuropsychopharmacology, 2022, v. 25, n. 9, p. 727, doi. 10.1093/ijnp/pyac031
- By:
- Publication type:
- Article
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 8, p. 977, doi. 10.3390/ph15080977
- By:
- Publication type:
- Article
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Drug Safety, 2022, v. 45, n. 6, p. 663, doi. 10.1007/s40264-022-01184-1
- By:
- Publication type:
- Article
The European Prescribing Exam: assessing whether European medical students can prescribe rationally and safely.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Liver Injury with Nintedanib: A Pharmacovigilance–Pharmacokinetic Appraisal.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 5, p. 645, doi. 10.3390/ph15050645
- By:
- Publication type:
- Article
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems.
- Published in:
- Journal of Nephrology (JNonline), 2022, v. 35, n. 3, p. 1017, doi. 10.1007/s40620-021-01191-y
- By:
- Publication type:
- Article
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 2, p. 247, doi. 10.1007/s40257-021-00645-0
- By:
- Publication type:
- Article
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.740707
- By:
- Publication type:
- Article
Developing medical artificial intelligence leaders: International university consortium approach.
- Published in:
- Medical Education, 2021, v. 55, n. 11, p. 1321, doi. 10.1111/medu.14635
- By:
- Publication type:
- Article
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 9, p. 983, doi. 10.1177/2047487320915663
- By:
- Publication type:
- Article
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 6, p. 1169, doi. 10.1007/s10096-020-04149-3
- By:
- Publication type:
- Article
Fluoroquinolones and Aortic Disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1758, doi. 10.3390/cancers13081758
- By:
- Publication type:
- Article
Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID‐19.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1533, doi. 10.1111/bcp.14459
- By:
- Publication type:
- Article
Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 3, p. 302, doi. 10.3390/pharmaceutics13030302
- By:
- Publication type:
- Article
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 186, n. 1, p. 219, doi. 10.1007/s10549-020-06001-w
- By:
- Publication type:
- Article
Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 2, p. 233, doi. 10.1007/s00228-020-02990-1
- By:
- Publication type:
- Article
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1277, doi. 10.1007/s40264-020-00975-8
- By:
- Publication type:
- Article
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 4, p. 449, doi. 10.1007/s11523-020-00738-6
- By:
- Publication type:
- Article
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors.
- Published in:
- In Vivo, 2020, v. 34, n. 3, p. 1333, doi. 10.21873/invivo.11910
- By:
- Publication type:
- Article
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 1, p. 71, doi. 10.1007/s00592-019-01378-7
- By:
- Publication type:
- Article
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study.
- Published in:
- BMC Pharmacology & Toxicology, 2019, v. 20, n. 1, p. 1, doi. 10.1186/s40360-019-0364-0
- By:
- Publication type:
- Article
µ‐opioid receptor, β‐endorphin, and cannabinoid receptor‐2 are increased in the colonic mucosa of irritable bowel syndrome patients.
- Published in:
- Neurogastroenterology & Motility, 2019, v. 31, n. 11, p. N.PAG, doi. 10.1111/nmo.13688
- By:
- Publication type:
- Article
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1228, doi. 10.1634/theoncologist.2019-0250
- By:
- Publication type:
- Article
Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors.
- Published in:
- Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01235
- By:
- Publication type:
- Article
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 12, p. 1633, doi. 10.1177/1352458518799598
- By:
- Publication type:
- Article
Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0211938
- By:
- Publication type:
- Article
Observational research on sodium glucose co‐transporter‐2 inhibitors: A real breakthrough?
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2711, doi. 10.1111/dom.13468
- By:
- Publication type:
- Article
Gender-differences of in vitro colonic motility after chemo- and radiotherapy in humans.
- Published in:
- BMC Pharmacology & Toxicology, 2018, v. 19, n. 1, p. N.PAG, doi. 10.1186/s40360-018-0238-x
- By:
- Publication type:
- Article
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations-authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- letter
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations.
- Published in:
- 2018
- By:
- Publication type:
- journal article